Cardiovascular Drugs Market: Navigating Growth Amidst Rising Global Health Burdens
The global cardiovascular drugs market stands at the epicenter of the pharmaceutical landscape, driven by the escalating prevalence of heart-related ailments, growing geriatric population, and expanding healthcare access in emerging markets. Cardiovascular diseases (CVDs) continue to be the leading cause of mortality globally, accounting for over 17.9 million deaths annually , according to the World Health Organization (WHO). This grim statistic underscores the critical need for effective cardiovascular therapeutics and highlights the immense market potential. Market Overview and Size The Cardiovascular Drugs Market is expected to register a CAGR of 4.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. This growth is largely fueled by the rising incidence of hypertension, coronary artery disease, arrhythmias, and other heart-related conditions. Several classes of drugs dominate the market landscape, including ...